Here are four notes:
1. Synergy is a biopharmaceutical company focused on the development and commercialization of novel GI therapies.
2. Mr. Sender has more than 25 years of financial leadership experience in the pharmaceutical and biopharmaceutical industries, most recently at Shire.
3. He most recently served as senior vice president, finance at the Shire.
4. He has also previously served as the founding CFO of Tengion, a biotechnology company in the field of regenerative medicine.
More articles on GI/endoscopy:
FDA clears FUJIFILM’s new medical visualization solution: 5 things to know
Gastroenterologist to know: Dr. Seth Hoffman of Ohio Gastroenterology
EndoChoice Q3 revenue up 30%, FDA recalls Custom Ultrasonics’ automated endoscope reprocessors — 5 GI/endoscopy company key notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
